Cynata Therapeutic (CYYNF) Given “Buy” Rating at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Cynata Therapeutic (OTC:CYYNF) in a research note released on Friday morning.

Cynata Therapeutic (OTC CYYNF) opened at 0.445 on Friday. Cynata Therapeutic has a 52-week low of $0.34 and a 52-week high of $0.50. The company’s market capitalization is $40.08 million.

TRADEMARK VIOLATION WARNING: This piece of content was first published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this piece of content on another site, it was stolen and reposted in violation of US & international trademark & copyright legislation. The legal version of this piece of content can be viewed at

Receive News & Ratings for Cynata Therapeutic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cynata Therapeutic and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply